GelStat Corp. (OTCMKTS:GSAC – Get Free Report) saw a large increase in short interest in the month of October. As of October 15th, there was short interest totaling 3,449 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 916,991 shares, the days-to-cover ratio is presently 0.0 days.
GelStat Stock Performance
Shares of OTCMKTS:GSAC opened at $0.00 on Monday. GelStat has a 52-week low of $0.00 and a 52-week high of $0.00.
GelStat Company Profile
GelStat Corporation is a specialty healthcare company associated with the development and marketing of over-the-counter products intended to address common health conditions. The company is best known for GelStat Migraine, a nonprescription product marketed for the temporary relief of migraine-related symptoms.
Historically, GelStat’s product portfolio also included other consumer healthcare offerings, including products positioned for sleep support and relief from cold-related symptoms.
Recommended Stories
- Five stocks we like better than GelStat
- Royal Caribbean Buys the Beach as Norwegian Fixes the Ship
- SK hynix Says Memory Demand Beats Supply Through 2030—What It Means for Micron and SanDisk
- STMicroelectronics Could Reach New Highs—Here’s What Needs to Happen
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
Receive News & Ratings for GelStat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GelStat and related companies with MarketBeat.com's FREE daily email newsletter.
